The Nova 301 Trial is looking to recruit approximately 25,000 people globally to see if an investigational mRNA vaccine can ...

On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

The newest case is the fifth to bring similar allegations against Moderna in the same court, with three others, all filed Nov ...

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...